Van Hulzen Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $2.83K | Sell |
|
|||||
|
2024
Q3 | $1.07M | Buy |
|
|||||
|
2024
Q2 | $1.84M | Buy |
|
|||||
|
2024
Q1 | $1M | Buy |
|
|||||
|
2023
Q4 | $1.15M | Buy |
|
|||||
|
2023
Q3 | $971K | Buy |
|
|||||
|
2023
Q2 | $841K | Buy |
|
|||||
|
2023
Q1 | $763K | Buy |
|
|||||
|
2022
Q4 | $555K | Buy |
|
|||||
|
2022
Q3 | $720K | Buy |
|
|||||
|
2022
Q2 | $748K | Buy |
|
|||||
|
2022
Q1 | $972K | Buy |
|
|||||
|
2021
Q4 | $756K | Buy |
|
|||||
|
2021
Q3 | $379K | Buy |
|